Login / Signup

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.

Caroul ChawarAlannah HillmerStephanie SangerAlessia D'EliaBalpreet PanesarLucy GuanDave Xiaofei XieNandini BansalAamna AbdullahFlavio KapczinskiGuillaume PareLehana ThabaneZainab Samaan
Published in: Addiction science & clinical practice (2021)
The results from this systematic review will aid in highlighting significant genetic variants that can be replicated in future OUD pharmacogenetics research to ascertain their role in patient-specific MOUD outcomes. Systematic review registration number CRD42020169121.
Keyphrases
  • systematic review
  • meta analyses
  • randomized controlled trial
  • type diabetes
  • genome wide
  • gene expression
  • current status
  • dna methylation
  • skeletal muscle
  • glycemic control
  • genome wide association